0001590934-20-000001.txt : 20200422 0001590934-20-000001.hdr.sgml : 20200422 20200422171446 ACCESSION NUMBER: 0001590934-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200422 DATE AS OF CHANGE: 20200422 EFFECTIVENESS DATE: 20200422 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Oricula Therapeutics LLC CENTRAL INDEX KEY: 0001590934 IRS NUMBER: 461984834 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-365611 FILM NUMBER: 20808558 BUSINESS ADDRESS: STREET 1: 474 39TH AVENUE EAST CITY: SEATTLE STATE: WA ZIP: 98112 BUSINESS PHONE: 206-322-7526 MAIL ADDRESS: STREET 1: 474 39TH AVENUE EAST CITY: SEATTLE STATE: WA ZIP: 98112 D 1 primary_doc.xml X0708 D LIVE 0001590934 Oricula Therapeutics LLC 474 39TH AVENUE EAST SEATTLE WA WASHINGTON 98112 206-322-7526 DELAWARE None None Limited Liability Company true Malcolm Gleser 474 39th Avenue E Seattle WA WASHINGTON 98112 Executive Officer Director Promoter Ed Rubel 474 39th Avenue E Seattle WA WASHINGTON 98112 Director Promoter Vince Groppi 474 39th Avenue E Seattle WA WASHINGTON 98112 Director Promoter Biotechnology Decline to Disclose 06b false true false true false 0 500000 0 500000 false 0 0 0 0 false Oricula Therapeutics LLC /s/ Malcolm Gleser Malcolm Gleser CEO 2020-04-22